Renaissance Technologies
FBRX icon

Renaissance Technologies’s Forte Biosciences FBRX Stock Holding History

Renaissance Technologies’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,200
Closed -$243K – 3393
2025
Q3 		$243K Buy
+16,200
New +$187K ﹤0.01% 3082
2024
Q3 		– Sell
-5,336
Closed -$71.6K – 3634
2024
Q2 		$71.6K Buy
5,336
+52
+1% +$840 ﹤0.01% 3241
2024
Q1 		$92K Buy
5,284
+92
+2% +$1.6K ﹤0.01% 3384
2023
Q4 		$107K Buy
5,192
+116
+2% +$1.62K ﹤0.01% 3290
2023
Q3 		$84K Sell
5,076
-3,116
-38% -$69.1K ﹤0.01% 3283
2023
Q2 		$213K Sell
8,192
-348
-4% -$9.04K ﹤0.01% 3276
2023
Q1 		$216K Sell
8,540
-2,560
-23% -$64.4K ﹤0.01% 3246
2022
Q4 		$278K Sell
11,100
-6,665
-38% -$171K ﹤0.01% 3258
2022
Q3 		$475K Buy
17,765
+9,097
+105% +$289K ﹤0.01% 2951
2022
Q2 		$282K Buy
8,668
+1,092
+14% +$34.7K ﹤0.01% 3486
2022
Q1 		$277K Buy
+7,576
New +$287K ﹤0.01% 3504
2021
Q2 		– Sell
-1,577
Closed -$1.35M – 3553
2021
Q1 		$1.35M Buy
1,577
+896
+132% +$734K ﹤0.01% 2461
2020
Q4 		$620K Buy
681
+188
+38% +$177K ﹤0.01% 2726
2020
Q3 		$598K Buy
+493
New +$327K ﹤0.01% 2754
2020
Q1 		– Sell
-121
Closed -$24K – 3540
2019
Q4 		$24K Sell
121
-909
-88% -$206K ﹤0.01% 3441
2019
Q3 		$256K Buy
1,030
+952
+1,221% +$1.44M ﹤0.01% 3079
2019
Q2 		$196K Buy
78
+4
+5% +$11.9K ﹤0.01% 3304
2019
Q1 		$302K Buy
+74
New +$286K ﹤0.01% 3093

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Renaissance Technologies's FBRX Position: Q4 2025 in Review

Renaissance Technologies sold out of Forte Biosciences (FBRX) in Q4 2025, closing a stake of 16,200 shares — an estimated $243K sold.

Renaissance Technologies first reported a position in FBRX in Q1 2019 and held it in 18 quarters. The position peaked at $1.35M in Q1 2021. 59 funds tracked by Wall St. Rank hold FBRX as of Q4 2025.

  • Renaissance Technologies reported no remaining Forte Biosciences position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 16,200 Forte Biosciences shares in Q4 2025, an estimated $243K.
  • Renaissance Technologies first reported a position in Forte Biosciences in Q1 2019 and held it in 18 quarters.
  • Renaissance Technologies's Forte Biosciences position peaked at $1.35M in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.